| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |